Results Conference Call
3Q22
Hospital Maternidade São Luiz Star - São Paulo, SP
- DISCLAIMER
The reader/investor should not rely solely on the information herein to make decisions with respect to trading the securities issued by Rede D'Or São Luiz. The document may also contain prospective statements, which are subject to risks and uncertainties as they are based on expectations of the company's management and on available information.
The company is under no obligation to update these statements. The Company's future financial situation, operating results, market share and competitive position may differ substantially from those expressed or suggested by forward-looking statements. Many factors and values that may impact these results are beyond the company's ability to control.
Future projects could differ materially due to market conditions, changes in laws or government policies, changes in operational conditions and costs, changes in project schedules, operating performance, demands by clients and consumers, commercial negotiations or other technical and economic factors. For more detailed information, please refer to our Financial Statements, Reference Form (Formulário de Referência) and other relevant information on our investor relations website: www.ir.rededor.com.br
3Q22 2
- CEO REMARKS
OPERATIONAL | COSTS AND |
HIGHLIGHTS | EXPENSES |
QUALITY | RECENT |
EVENTS |
3Q22 3
- QUARTERLY HIGHLIGHTS
Solid operational results
Operational efficiency
+5.3%
(3Q22 vs. 2Q22)
Average ticket
sequential evolution driven by contracts readjustments
+7.4%
(3Q22 vs. 2Q22)
Oncology average ticket
acceleration
Materials and medicines
as a percentage of gross revenues returning to pre-pandemic levels
(% over gross revenues)
24.9%
(in 3Q22)
79.5%
(in 3Q22)
+9.7%
(3Q22; YoY)
Occupancy rate approximately
1 pp above Q3 historical average
Continuous expansion of
operational beds
+13.2%
(3Q22; YoY)
+14.2%
(3Q22; YoY)
Solid growth of surgery volume over same-base assets
Net revenues reaches new quarterly record
21.2% 22.0% | 20.5% | of EBITDA margin, | ||||||||
+1.2 pp YoY expansion | ||||||||||
18.5% | ||||||||||
and +0.1 pp vs. 2Q22 | ||||||||||
9M19 9M20 9M21 9M22
Cash generation
R$3.4 bi Operational cash flow before
(in 9M22) interest and taxes, +135.4% YoY
3Q22 4
- OPERATIONAL AND COVID-19 EVOLUTION
Patient-day volume and average occupancy rate
(hospitalization in thousands; %)
76.8% | 73.8% | 75.0% | 77.6% 79.5% 83.0% | 78.4% 76.5% 78.1% | 82.6% 79.5% | ||||||||
69.7% | |||||||||||||
707 | 701 | ||||||||||||
61.2% | 628 | 625 | 616 | 645 | |||||||||
554 | |||||||||||||
480 | 475 | 513 | |||||||||||
464 | 454 | ||||||||||||
388 | |||||||||||||
3Q19 | 4Q19 | 1Q20 | 2Q20 | 3Q20 | 4Q20 | 1Q21 | 2Q21 | 3Q21 | 4Q21 | 1Q22 | 2Q22 | 3Q22 | |
YoY change | +12.7% | +11.1% | +3.2% | -20.6% | -1.2% | +10.7% | +21.9% | +62.0% | +31.7% | +20.0% | +16.5% | +12.5% | +12.2% |
Covid-19patient-day evolution at Rede D'Or units
(Daily volume between March 2021 and October 2022)
-92% |
- Patient-dayvolumes grew 12.2% YoY in 3Q22 with average occupancy rate at 79.5%, in
line with historical seasonality versus 2Q22. Volume of Covid-19 patients continues to | ||
decrease annually; excluding Covid-19 patients, patient-day increased 22.3% YoY in 3Q22. | 3Q22 | 5 |
This is an excerpt of the original content. To continue reading it, access the original document here.